Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Name: Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
License: Public Domain

Sun Yat-sen University

ClinicalTrials.gov · Datasets · License: Public Domain

complete remission rate， crr, progression free survival, overall survival, adverse event, duration of response

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208453
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.